OptiBiotix Health Plc (OPBXF) Research

OptiBiotix Health Plc is a life sciences enterprise based in the United Kingdom, specializing in the research and development of innovative microbiome modulators. The company's core activity involves pinpointing and crafting unique microbial strains, compounds, and formulations. These are then integrated into food ingredients, dietary supplements, and active agents, with the objective of positively influencing human physiological processes and delivering significant health advantages. Its comprehensive range of products targets key aspects of well-being. For effective and hunger-free weight management, OptiBiotix offers Slimbiome, a natural ingredient, and SlimBiome Medical, a natural supplement. CholBiome is a food supplement formulated to support healthy cholesterol levels. The probiotic Lactobacillus plantarum LPLDL contributes to cardiovascular health and overall vitality. LPGOS, a beneficial galactooligosaccharide, is incorporated into various food products and applications to lower cardiovascular risk factors and promote better health. WellBiome, a blend of functional fibers and minerals, bolsters general health and well-being by encouraging a diverse gut microbiome. Additionally, Sweetbiotix provides a sweetening solution for food and beverages. Fundamentally, OptiBiotix's solutions are engineered to prevent and manage prevalent chronic lifestyle diseases, including obesity, hypercholesterolemia, adverse lipid profiles, and diabetes. The company was established in 2012 and operates from its headquarters in York, United Kingdom.

Open OptiBiotix Health Plc (OPBXF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.